STAT October 4, 2023
Lev Facher

No medication is approved to treat addiction to either methamphetamine or cocaine. But the Food and Drug Administration is taking steps to fill that glaring gap in addiction medicine.

The agency on Wednesday issued draft guidance that encourages drug manufacturers to develop new treatments that could help treat addiction to meth, cocaine, or prescription stimulants. While the country’s current drug overdose crisis is largely driven by opioids, stimulant use has skyrocketed in recent years. An increasing share of drug deaths are now attributed to a combination of opioids and stimulants, or, in some cases, stimulants alone.

The FDA’s move comes amid increased recognition of the threat posed by stimulants, and the continued lack of medication options available for health...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Mental Health, Provider
Who’s Leading the FDA’s AI Race? Top Medical Specialties and Companies to Watch
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee

Share This Article